# Jochen Seufert

**Type:** Researchers  
**Canonical URL:** https://scholariq.org/researchers/jochen-seufert/

## Facts

| Field | Value |
| --- | --- |
| Citations | 19,498 |
| Field | Diabetes Treatment and Management |
| h-index | 55 |
| i10-index | 157 |
| Last Known Institution | University of Freiburg |
| OpenAlex ID | https://openalex.org/A5056074989 |
| ORCID iD | 0000-0001-5654-7310 |
| Works | 633 |

## Researcher papers

- [Semaglutide and Cardiovascular Outcomes in Patients with Type 2 Diabetes](https://scholariq.org/papers/semaglutide-and-cardiovascular-outcomes-in-patients-with-type-2-diabetes/)
- [Albiglutide and cardiovascular outcomes in patients with type 2 diabetes and cardiovascular disease (Harmony Outcomes): a double-blind, randomised placebo-controlled trial](https://scholariq.org/papers/albiglutide-and-cardiovascular-outcomes-in-patients-with-type-2-diabetes-and/)
- [Physiology and role of irisin in glucose homeostasis](https://scholariq.org/papers/physiology-and-role-of-irisin-in-glucose-homeostasis/)
- [Degeneration of substantia nigra in chronic Parkinson's disease visualized by transcranial color-coded real-time sonography](https://scholariq.org/papers/degeneration-of-substantia-nigra-in-chronic-parkinson-s-disease-visualized-by/)
- [Leptin Suppression of Insulin Secretion and Gene Expression in Human Pancreatic Islets: Implications for the Development of Adipogenic Diabetes Mellitus1](https://scholariq.org/papers/leptin-suppression-of-insulin-secretion-and-gene-expression-in-human-pancreatic/)
- [Leptin Effects on Pancreatic β-Cell Gene Expression and Function](https://scholariq.org/papers/leptin-effects-on-pancreatic-cell-gene-expression-and-function/)
- [Cardiovascular and Cerebrovascular Comorbidities of Hypokalemic and Normokalemic Primary Aldosteronism: Results of the German Conn’s Registry](https://scholariq.org/papers/cardiovascular-and-cerebrovascular-comorbidities-of-hypokalemic-and-normokalemic/)
- [Efficacy and Safety of Dapagliflozin in Patients With Inadequately Controlled Type 1 Diabetes (the DEPICT-2 Study): 24-Week Results From a Randomized Controlled Trial](https://scholariq.org/papers/efficacy-and-safety-of-dapagliflozin-in-patients-with-inadequately-controlled-2/)
- [Combination of Lenvatinib and Pembrolizumab Is an Effective Treatment Option for Anaplastic and Poorly Differentiated Thyroid Carcinoma](https://scholariq.org/papers/combination-of-lenvatinib-and-pembrolizumab-is-an-effective-treatment-option-for/)
- [Adrenal Venous Sampling](https://scholariq.org/papers/adrenal-venous-sampling/)
- [Effects of once-weekly subcutaneous semaglutide on kidney function and safety in patients with type 2 diabetes: a post-hoc analysis of the SUSTAIN 1–7 randomised controlled trials](https://scholariq.org/papers/effects-of-once-weekly-subcutaneous-semaglutide-on-kidney-function-and-safety-in/)

## Researcher topics

- [Diabetes Treatment and Management](https://scholariq.org/topics/diabetes-treatment-and-management/)
- [Diabetes Management and Research](https://scholariq.org/topics/diabetes-management-and-research/)
- [Pancreatic function and diabetes](https://scholariq.org/topics/pancreatic-function-and-diabetes/)
- [Diabetes and associated disorders](https://scholariq.org/topics/diabetes-and-associated-disorders/)
- [Metabolism, Diabetes, and Cancer](https://scholariq.org/topics/metabolism-diabetes-and-cancer/)

## Researcher university

- [University of Freiburg](https://scholariq.org/institutions/university-of-freiburg/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.